AT351158B - Verfahren zur herstellung eines antihaemophilen faktor (ahf) enthaltenden, festen, vorzugsweise lyophilisierten mittels - Google Patents

Verfahren zur herstellung eines antihaemophilen faktor (ahf) enthaltenden, festen, vorzugsweise lyophilisierten mittels

Info

Publication number
AT351158B
AT351158B AT956676A AT956676A AT351158B AT 351158 B AT351158 B AT 351158B AT 956676 A AT956676 A AT 956676A AT 956676 A AT956676 A AT 956676A AT 351158 B AT351158 B AT 351158B
Authority
AT
Austria
Prior art keywords
ahf
producing
containing solid
preferably lyophilized
lyophilized agents
Prior art date
Application number
AT956676A
Other languages
English (en)
Other versions
ATA956676A (de
Original Assignee
Baxter Travenol Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/729,758 external-priority patent/US4089944A/en
Application filed by Baxter Travenol Lab filed Critical Baxter Travenol Lab
Publication of ATA956676A publication Critical patent/ATA956676A/de
Application granted granted Critical
Publication of AT351158B publication Critical patent/AT351158B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT956676A 1975-12-22 1976-12-22 Verfahren zur herstellung eines antihaemophilen faktor (ahf) enthaltenden, festen, vorzugsweise lyophilisierten mittels AT351158B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64317875A 1975-12-22 1975-12-22
US05/729,758 US4089944A (en) 1975-12-22 1976-10-05 Rapidly solubilized AHF composition and process for preparing same

Publications (2)

Publication Number Publication Date
ATA956676A ATA956676A (de) 1978-12-15
AT351158B true AT351158B (de) 1979-07-10

Family

ID=27094202

Family Applications (1)

Application Number Title Priority Date Filing Date
AT956676A AT351158B (de) 1975-12-22 1976-12-22 Verfahren zur herstellung eines antihaemophilen faktor (ahf) enthaltenden, festen, vorzugsweise lyophilisierten mittels

Country Status (7)

Country Link
JP (1) JPS5282716A (de)
AT (1) AT351158B (de)
CA (1) CA1066189A (de)
DE (1) DE2653534C2 (de)
ES (1) ES454453A1 (de)
GB (1) GB1540610A (de)
MX (1) MX4730E (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186192A (en) * 1978-12-18 1980-01-29 Cutter Laboratories, Inc. Stabilized immune serum globulin
DE2916711A1 (de) * 1979-04-25 1980-11-06 Behringwerke Ag Blutgerinnungsfaktoren und verfahren zu ihrer herstellung
DE3432083A1 (de) * 1984-08-31 1986-03-06 Behringwerke Ag, 3550 Marburg Pasteurisierte, isoagglutininfreie faktor viii-praeparation und verfahren zu ihrer herstellung
HUP9701554D0 (en) * 1997-09-18 1997-11-28 Human Oltoanyagtermeloe Gyogys Pharmaceutical composition containing plazma proteins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2826533A (en) * 1954-03-15 1958-03-11 Cutter Lab Stable fibrinogen solutions and method for producing same

Also Published As

Publication number Publication date
JPS5282716A (en) 1977-07-11
DE2653534A1 (de) 1977-06-30
MX4730E (es) 1982-08-24
GB1540610A (en) 1979-02-14
ATA956676A (de) 1978-12-15
ES454453A1 (es) 1978-04-01
DE2653534C2 (de) 1986-08-28
CA1066189A (en) 1979-11-13

Similar Documents

Publication Publication Date Title
AT355947B (de) Verfahren zur herstellung eines oxydischen schleifmittels
DD130857A5 (de) Verfahren zur herstellung von n-phosphonomethylglycintriestern
DD128681A5 (de) Verfahren zur herstellung von n hoch 2-arylsulfonyl-l-argininamiden
ATA74675A (de) Verfahren zur herstellung von neuen l- oder dl-tyrosinamiden
AT334549B (de) Verfahren zur herstellung von polyvinylpyrrolidon-jod
DD129330A5 (de) Verfahren zur herstellung von antitumorsubstanzen
DD124592A5 (de) Verfahren zur herstellung von ungesaettigten aldehyden und saeuren
DD130036A5 (de) Verfahren zur herstellung von optisch aktiven 11-desoxy-16-aryloxy-omega-tetranorprostaglandinen
DD128590A5 (de) Verfahren zur herstellung optisch aktiver 11-desoxy-16-aryl-omega-tetranorprostaglandine
DD129326A5 (de) Verfahren zur herstellung von 1,4-diphenyl-3-pyrazolin-5-onen
AT351278B (de) Verfahren zur herstellung von molybdaen- legierungen
AT351158B (de) Verfahren zur herstellung eines antihaemophilen faktor (ahf) enthaltenden, festen, vorzugsweise lyophilisierten mittels
DD132270A5 (de) Verfahren zur herstellung von depot-steroidestern
AT358737B (de) Verfahren zur herstellung eines antihaemophilen mittels
AT351768B (de) Verfahren zur herstellung eines antistruktur- mittelgemisches
ATA3476A (de) Verfahren zur herstellung von neuen verbindungen
AT346294B (de) Verfahren zur herstellung von 1,1-dihalogen-4- methyl-1,3-pentadienen
DD129783A5 (de) Verfahren zur herstellung eines enons
DD128704A5 (de) Verfahren zur herstellung von 2,9-dioxatricyclo(4,3,1,0 hoch 3,hoch 7)decanen
ATA289676A (de) Verfahren zur herstellung von molybdaen- legierungen
ATA505976A (de) Verfahren zur herstellung des 5-cyan-4-metyl- oxazols(1,3)
AT352914B (de) Verfahren zur herstellung von polyen- verbindungen
AT346280B (de) Verfahren zur herstellung von metaboratloesungen
ATA932875A (de) Verfahren zur herstellung von salzen von monoestern der kohlensaure
DD130935A5 (de) Verfahren zur herstellung von propionsaeureestern

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee